SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dumb SEND IT

Community members are actively rallying around DSIT, pushing for aggressive buying and holding to drive the token toward higher market cap milestones. The project, led by a highly active developer, has gained traction on social platforms with followers citing a 'dumb send it' energy and anticipation of upcoming chart updates and airdrop incentives.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is capturing significant community attention as investors debate its long-term potential and consolidation patterns. Enthusiasts are actively sharing bullish outlooks and comparing the asset to other meme coins, while some traders express frustration over current price stagnation and recent market volatility.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing heightened community interest driven by speculation surrounding upcoming burns and broader market sentiment regarding potential regulatory clarity. Holders are actively discussing long-term recovery efforts, including project development on the chain and hopes for a major supply reversal, while skeptics remain focused on the token's historical volatility.

"What's Updog?" is a Community Led token.

UpDog

UpDog is surging in visibility as community members rally around its organic growth and long-standing presence on the Solana network. Investors are actively discussing whale accumulation and trending activity, fueling a wave of bullish sentiment around the project's longevity.

The White Alien has arrived. The countdown to domination starts now.

The White Alien

Investors are actively circulating the token across social platforms as the community rallies around its unique aesthetic and speculative potential. The conversation is largely driven by collective engagement and influencer mentions, fueling increased interest within the meme coin sector.

ETHGas is a Blockspace Infrastructure protocol that decomposes Ethereum blockspace into tradable, composable block units, enabling real‑time block production and laying the foundation for a crypto‑native commodities market for gas. By restructuring gas as a financial primitive, ETHGas unlocks: - Faster block times (sub‑second confirmations vs 12‑second Ethereum blocks) through real‑time sequencing. - A futures/forward market for gas, enabling the creation of a native Ethereum yield curve. - Gas abstraction for end users via the Open Gas Initiative, removing gas volatility and shifting costs to protocols. - Commoditization of blockspace, similar to energy or metals markets in traditional finance.

ETHGas

GWEI is attracting significant investor attention as its novel approach to predicting and locking in Ethereum gas fees gains traction among users. The community is actively discussing its recent momentum, exchange listings, and perceived utility in solving long-standing friction points within the Ethereum ecosystem.

Diamondback Energy, Inc. is an independent oil and natural gas company, which engages in the acquisition, development, exploration, and exploitation of unconventional, onshore oil, and natural gas reserves. It operates through the Upstream and Midstream Services segments. The Upstream segment focuses on the Permian Basin operations in West Texas. The Midstream Services segment is involved in the Midland and Delaware Basins. The company was founded in December 2007 and is headquartered in Midland, TX.

Diamondback Energy Inc

Diamondback Energy is capturing investor interest as market analysts highlight its strong production performance and operational efficiency within the Permian Basin amid ongoing geopolitical volatility in energy markets. The community remains focused on the company's dividend stability, capital return strategy, and its resilience as a pure-play energy operator despite broader sector fluctuations.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing intense social media debate, with long-term holders expressing frustration over stagnant price action while others remain committed to the project's enterprise focus and Japanese regulatory status. Community discussion is currently fixated on upcoming business news and the potential for a long-term turnaround, leading to high-conviction debates between those calling it a failed project and those continuing to accumulate during market volatility.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Valero Energy is trending as investors weigh tightening refining margins against geopolitical volatility, while the community discusses the stock's potential as a play on shifting global energy supply chains. Market participants are closely watching the balance between operational resilience at its facilities and the broader macroeconomic impact of energy price fluctuations.

Marathon Petroleum Corp. engages in the refining, marketing, and transportation of petroleum products. It operates through the Refining and Marketing, and Midstream segments. The Refining and Marketing segment includes refining crude oil and other feedstocks, purchasing ethanol, and refined products for resale and distribution of refined products. The Midstream segment refers to transportation, storing, distribution, and marketing of crude oil and refined products. The company was founded in 1887 and is headquartered in Findlay, OH.

Marathon Petroleum Corp

Marathon Petroleum is trending as traders debate the company's reliance on midstream assets like MPLX to offset refining margin pressures amid volatile energy prices. The community is actively discussing the stock's recent valuation correction and conflicting outlooks from analysts regarding its long-term growth potential and capital return programs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunic (NASDAQ:IMUX) Shares to Reverse Split on Monday, April 27th

Immunic, Inc. (NASDAQ:IMUX - Free Report) shares are set to reverse split on Monday, April 27th. The 1-10 reverse split was announced on Thursday, April 23rd. The number of shares owned by...

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

Immunic, Inc. Announces 1-for-10 Reverse Stock Split Immunic, Inc. Announces 1-for-10 Reverse Stock Split PR Newswire NEW YORK, April 23, 2026 NEW YORK, April 23, 2026 /PRNewswire/ -- Immunic, Inc...

Immunic (NASDAQ:IMUX) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of Immunic from a "hold" rating to a "sell" rating in a research note on Sunday...

Immunic's Next-Gen Oral Multiple Sclerosis Drug Poised To Capture Share, Analyst Says

Stifel initiates coverage on Immunic (IMUX) with a Buy rating. Analysts see potential for VidoCa to disrupt the MS market via better safety.read more...

Immunic, Inc. (NASDAQ:IMUX) Receives Average Recommendation of "Moderate Buy" from Analysts

Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine research firms that are presently covering the firm, MarketBeat reports. One analyst has...

Immunic Stock Scheduled to Reverse Split on Monday, April 27th (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX - Free Report) shares are set to reverse split before the market opens on Monday, April 27th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, April 26th...

Immunic (NASDAQ:IMUX) Downgraded to Hold Rating by D. Boral Capital

D. Boral Capital cut Immunic from a "buy" rating to a "hold" rating in a research note on Wednesday...

Wall Street Zen Upgrades Immunic (NASDAQ:IMUX) to Hold

Wall Street Zen raised shares of Immunic from a "sell" rating to a "hold" rating in a research note on Saturday...

Immunic to Participate in Scientific and Medical Conferences in April

Immunic to Participate in Scientific and Medical Conferences in April Immunic to Participate in Scientific and Medical Conferences in April PR Newswire NEW YORK, April 9, 2026 NEW YORK, April 9, 2026...

<ul class="summary-bullets"><li>IMUX shares have consistently traded above $1 since February 27.</li><li>The company appointed Jon Congleton, CEO of Mineralys Therapeutics, to its board of directors on Tuesday.</li><li>It recently closed a private placement of up to $400 million to support late-stage trials for the treatment of multiple sclerosis.</li></ul>Shares of Immunic, Inc (IMUX) gained around 7% on Wednesday after the company said it had regained compliance with Nasdaq’s listing rules on March 26.The firm regained compliance after the stock closed at or above $1 for at least 20 consecutive business days. The update removes concerns about a potential delisting from the Nasdaq Capital Market.<a href="https://stocktwits.com/symbol/IMUX">IMUX shares</a> have consistently&nbsp;traded above $1 since February 27.On Tuesday, the company appointed Jon Congleton, CEO of Mineralys Therapeutics, to its board of directors.&nbsp;<h2 class="st-heading-2">Immunic Secures Patent And Raises $400 Million</h2>Last month, the European Patent Office granted Immunic a key patent covering dosing regimens for its lead drug, Vidofludimus Calcium, to treat patients with&nbsp;multiple sclerosis. The protection is expected to last until 2038, with a potential extension to 2043.&nbsp;The patent broadly covers multiple forms of the drug, ensuring strong exclusivity across Europe and building on earlier approval from the United States Patent and Trademark Office.The company also closed a private placement of up to $400 million, led by BVF Partners. Immunic secured $200 million upfront, with additional funding tied to future warrants. The company said the funds will support late-stage trials for multiple sclerosis, aimed at helping slow disease progression.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits remained in the ‘bearish’ zone over the past 24 hours.One user highlighted the potential for a reverse share split.<stembedurl>https://stocktwits.com/ccledez/message/649165039</stembedurl>Another user was bullish about Congleton’s appointment.<stembedurl>https://stocktwits.com/Mvvh1987/message/649022575</stembedurl>Year-to-date, the stock has gained more than 113%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

IMUX Stock Jumps 6% Pre-Market Today – Here’s The Latest Update On Its Compliance With Nasdaq Listing Rules 

Shares of Immunic, Inc (IMUX) gained around 6% in pre-market trading on Wednesday after the company said it had regained compliance with Nasdaq’s listing rules on March 26.

Equity

The company regained compliance after the stock closed at or above $1 for at least 20 consecutive business days.

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.09	--	--	N/A
Q4 '25	-$0.09	--	--	N/A
Q3 '25	-$0.14	-$0.13	9.30%	BEAT
Q2 '25	-$0.16	-$0.20	-26.74%	MISSED
Q1 '25	-$0.25	--	--	N/A

IMUX
Immunic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest IMUX News

IMUXImmunic Inc